95
Participants
Start Date
November 15, 2017
Primary Completion Date
July 18, 2022
Study Completion Date
July 18, 2022
Luspatercept
Luspatercept is a recombinant fusion protein consisting of a modified form of the extracellular domain of the human active in receptor type IIB linked to the IgG1 Fc domain. Luspatercept, through a mechanism of action different from erythropoietin, works to correct ineffective erythropoiesis by promoting late-stage maturation of erythroblasts.
Local Institution - 104, New York
Mount Sinai Medical Center, New York
Istituto Clinico Humanitas, Rozzano (MI)
Local Institution - 303, Rozzano (MI)
Local Institution - 302, Varese
Ospedale di Circolo di Varese, Varese
Azienda Ospedaliera Papa Giovanni XXIII, Bergamo
Local Institution - 304, Bergamo
Fondazione IRCCS Policlinico San Matteo, Pavia
Local Institution - 301, Pavia
CHRU de Brest - Hopital Morvan, Brest
Local Institution - 203, Brest
Local Institution - 101, Jacksonville
Mayo Clinic - Jacksonville, Jacksonville
Local Institution - 107, Orange City
Mid Florida Hematology and Oncology Centers, PA, Orange City
H. Lee Moffitt Cancer Center and Research Institute, Tampa
Local Institution - 108, Tampa
Cleveland Clinic, Cleveland
Local Institution - 109, Cleveland
Azienda Ospedaliera Universitaria Careggi, Florence
Local Institution - 300, Florence
Avera Research Institute, Sioux Falls
Local Institution - 105, Sioux Falls
Centre Hospitalier de Lens, Lens
Local Institution - 201, Lens
Hopital Saint Louis, Paris
Local Institution - 200, Paris
Local Institution - 100, Houston
MD Anderson Cancer Center The University of Texas, Houston
Local Institution - 106, San Antonio
University of Texas Health Science Center at San Antonio, San Antonio
Local Institution - 102, Phoenix
Mayo Clinic - Arizona, Phoenix
Local Institution - 103, Stanford
Stanford Cancer Center, Stanford
Gustave Roussy, Villejuif
Local Institution - 202, Villejuif
Belfast Health and Social Care Trust, Belfast Northern Ireland
Local Institution - 404, Cardiff
University Hospital of Wales, Cardiff
Local Institution - 400, Headington, Oxford
University of Oxford, Headington, Oxford
Guy's and St Thomas' NHS Foundation Trust - Guy's Hospital, London
Local Institution - 403, London
Imperial College London, London
Local Institution - 402, London
Lead Sponsor
Celgene
INDUSTRY